Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Clinical trial NCT07712536 · COMPLETED

Trial details

NCT number: NCT07712536
Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)

Start date: 2025-06-04
Primary completion: 2025-12-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.